These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Polymorphisms and probable lack of mutation in the WAF1-CIP1 gene in colorectal cancer. Li YJ; Laurent-Puig P; Salmon RJ; Thomas G; Hamelin R Oncogene; 1995 Feb; 10(3):599-601. PubMed ID: 7845685 [TBL] [Abstract][Full Text] [Related]
46. Patterns of p21(waf1/cip1) expression in non-papillomatous nasal mucosa, endophytic sinonasal papillomas, and associated carcinomas. Schwerer MJ; Sailer A; Kraft K; Baczako K; Maier H J Clin Pathol; 2001 Nov; 54(11):871-6. PubMed ID: 11684723 [TBL] [Abstract][Full Text] [Related]
47. Decreased expression and rare somatic mutation of the CIP1/WAF1 gene in human hepatocellular carcinoma. Furutani M; Arii S; Tanaka H; Mise M; Niwano M; Harada T; Higashitsuji H; Imamura M; Fujita J Cancer Lett; 1997 Jan; 111(1-2):191-7. PubMed ID: 9022146 [TBL] [Abstract][Full Text] [Related]
48. p21/WAF1, p53 and PCNA expression and p53 mutation status in hepatocellular carcinoma. Qin LF; Ng IO; Fan ST; Ng M Int J Cancer; 1998 Aug; 79(4):424-8. PubMed ID: 9699537 [TBL] [Abstract][Full Text] [Related]
49. Nuclear accumulation of p53 correlates significantly with clinical features and inversely with the expression of the cyclin-dependent kinase inhibitor p21(WAF1/CIP1) in pancreatic cancer. Harada N; Gansauge S; Gansauge F; Gause H; Shimoyama S; Imaizumi T; Mattfeld T; Schoenberg MH; Beger HG Br J Cancer; 1997; 76(3):299-305. PubMed ID: 9252195 [TBL] [Abstract][Full Text] [Related]
50. Subcellular localisation of cyclin B, Cdc2 and p21(WAF1/CIP1) in breast cancer. association with prognosis. Winters ZE; Hunt NC; Bradburn MJ; Royds JA; Turley H; Harris AL; Norbury CJ Eur J Cancer; 2001 Dec; 37(18):2405-12. PubMed ID: 11720835 [TBL] [Abstract][Full Text] [Related]
51. Frequent and heterogeneous expression of cyclin-dependent kinase inhibitor WAF1/p21 protein and mRNA in urothelial carcinoma. Clasen S; Schulz WA; Gerharz CD; Grimm MO; Christoph F; Schmitz-Dräger BJ Br J Cancer; 1998 Feb; 77(4):515-21. PubMed ID: 9484805 [TBL] [Abstract][Full Text] [Related]
52. Evidence of gene deletion of p21 (WAF1/CIP1), a cyclin-dependent protein kinase inhibitor, in thyroid carcinomas. Shi Y; Zou M; Farid NR; al-Sedairy ST Br J Cancer; 1996 Nov; 74(9):1336-41. PubMed ID: 8912526 [TBL] [Abstract][Full Text] [Related]
53. WAF1/Cip1 gene polymorphism and expression in carcinomas of the breast, ovary, and endometrium. Lukas J; Groshen S; Saffari B; Niu N; Reles A; Wen WH; Felix J; Jones LA; Hall FL; Press MF Am J Pathol; 1997 Jan; 150(1):167-75. PubMed ID: 9006333 [TBL] [Abstract][Full Text] [Related]
54. Prognostic significance of p21WAF1/CIP1 expression in tongue squamous cell carcinomas. Xie X; Clausen OP; Boysen M Arch Otolaryngol Head Neck Surg; 2002 Aug; 128(8):897-902. PubMed ID: 12162767 [TBL] [Abstract][Full Text] [Related]
55. Association of increased radiocurability of murine carcinomas with low constitutive expression of p21(WAF1/CIP1) protein. Akimoto T; Seong J; Hunter NR; Buchmiller L; Mason K; Milas L Int J Radiat Oncol Biol Phys; 1999 May; 44(2):413-9. PubMed ID: 10760438 [TBL] [Abstract][Full Text] [Related]
56. A single nucleotide substitution at codon 31 (Ser/Arg) defines a polymorphism in a highly conserved region of the p53-inducible gene WAF1/CIP1. Chedid M; Michieli P; Lengel C; Huppi K; Givol D Oncogene; 1994 Oct; 9(10):3021-4. PubMed ID: 8084608 [TBL] [Abstract][Full Text] [Related]
57. Expression of p21(WAF1/CIP1) and p53 proteins in gastric carcinoma: its relationships with cell proliferation activity and prognosis. Liu XP; Tsushimi K; Tsushimi M; Kawauchi S; Oga A; Furuya T; Sasaki K Cancer Lett; 2001 Sep; 170(2):183-9. PubMed ID: 11463497 [TBL] [Abstract][Full Text] [Related]
58. Aberrant p21(CIP1/WAF1) protein accumulation in head-and-neck cancer. Erber R; Klein W; Andl T; Enders C; Born AI; Conradt C; Bartek J; Bosch FX Int J Cancer; 1997 Aug; 74(4):383-9. PubMed ID: 9291426 [TBL] [Abstract][Full Text] [Related]
59. Analysis of p53, p21(Waf1/Cip1) and TGF-beta(3) immunohistochemical staining in Bowen's disease. Kawakami T; Soma Y; Mizoguchi M; Saito R Dermatology; 2001; 202(1):9-15. PubMed ID: 11244221 [TBL] [Abstract][Full Text] [Related]
60. Cyclin D1 and p21 in ulcerative colitis-related inflammation and epithelial neoplasia: a study of aberrant expression and underlying mechanisms. Wong NA; Mayer NJ; Anderson CE; McKenzie HC; Morris RG; Diebold J; Mayr D; Brock IW; Royds JA; Gilmour HM; Harrison DJ Hum Pathol; 2003 Jun; 34(6):580-8. PubMed ID: 12827612 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]